View drug registration information details.
| Items | Registration information |
|---|
| ID | 1570 |
|---|
| No | 1570 |
|---|
| Brand Name | BEVAAS 400 |
|---|
| Ingredients | BEVACIZUMAB (R-DNA ORIGIN) 400 MG/16 ML |
|---|
| Dosage Form | SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL X 16 ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | METASTATIC COLORECTAL CANCER, NON SQUAMOUS NON SMALL CELL LUNG CANCER, GLIOBLASTOMA, METASTATIC RENAL CELL CARCINOMA, METASTATIC BREAST CANCER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | STERILE, CLEAR, COLORLESS AND PRESERVATIVE-FREE SOLUTION |
|---|
| Note | |
|---|
| License Owner | LAO NIYOM PHARMA SOLE CO.,LTD |
|---|
| Manufacturer | HETERO BIOPHARMA LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 12 I 5364/22 |
|---|
| FDD Registration Date | 30-DEC-2022 |
|---|
| Expiry Date | 29-DEC-2025 |
|---|
Back to drug list
|
